At Pearlman Aesthetic Surgery, we use these science-backed peptides to support sustainable weight loss
Formulation vehicle influences absorption substantially
However, the use of animal models is expensive, requires a lot of time and expertise, has low throughput potential, poses ethical issues, but most importantly, these models often do not correlate to human systems (Barr-Sinoussi and Montagutelli 2015)
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Microarray studies have identified changes in the expression of genes involved in cell cycle regulation, apoptosis, and stress response following Epithalon treatment